2013
DOI: 10.2174/13894501113149990154
|View full text |Cite
|
Sign up to set email alerts
|

Inflammation, Serotonin and Major Depression

Abstract: The understanding of the neurobiological processes leading to major depressive disorder (MDD) is an active field of research in the scientific community. For years, the alteration of monoamine neurotransmission, in particular serotonin (5-HT), has been considered the most significant pathophysiological mechanism of the disorder. However, biological data supporting the postulated MDD-related monoamine alterations have been inconclusive, and the use of monoaminergic antidepressants has not yielded the expected r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
61
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 92 publications
(62 citation statements)
references
References 0 publications
0
61
0
1
Order By: Relevance
“…According to the cytokine hypothesis, depressive disorders are related to increased production of cytokines, including interleukins, tumor necrosis factor alfa (TNF-α), and interferon-α and -γ. 1 A meta-analysis of cytokines in major depression shows higher concentrations of pro-inflammatory cytokines IL-6 and TNF-α in depressed patients compared with control subjects. 2 Fluoxetine is an antidepressant from the group of selective serotonin reuptake inhibitors (SSRI).…”
Section: Introductionmentioning
confidence: 99%
“…According to the cytokine hypothesis, depressive disorders are related to increased production of cytokines, including interleukins, tumor necrosis factor alfa (TNF-α), and interferon-α and -γ. 1 A meta-analysis of cytokines in major depression shows higher concentrations of pro-inflammatory cytokines IL-6 and TNF-α in depressed patients compared with control subjects. 2 Fluoxetine is an antidepressant from the group of selective serotonin reuptake inhibitors (SSRI).…”
Section: Introductionmentioning
confidence: 99%
“…This implies a strong competition between serotonin and the first downstream metabolites from the kynurenine pathway, kynurenine, for the available tryptophan, as described below. In inflammatory conditions, more kynurenine is produced on the expenses of serotonin [43,44], which, if happens also in the brain, results in behavioral changes including persistent sadness, loss of interest, and decreased energy levels [45] (Figure 1A). …”
Section: Gastrointestinal Inflammation and Depressionmentioning
confidence: 99%
“…Depression could be due to a stress-related increase in the production of cytokines such as ILs, TNF-α, IFN-α, IFN-β, and IFN-γ, which, in turn, up-regulate indoleamine 2,3-dioxygenase (IDO) expression [62][63][64][65] . IDO converts tryptophan, the precursor of 5-HT, to kynurenine; so IDO activation leads to reduced levels of tryptophan and thus reduced central 5-HT synthesis [66][67][68] .…”
Section: -Hydroxytryptamine Pro-inflammatory Cytokines Havementioning
confidence: 99%